Strong Cresemba (isavuconazole) Sales Performance in Asia Pacific and China Triggers Milestone Payment to Basilea

Strong Cresemba (isavuconazole) Sales Performance in Asia Pacific and China Triggers Milestone Payment to Basilea In recent years, the pharmaceutical landscape has witnessed significant advancements in antifungal treatments, with Basilea Pharmaceutica AG Allschwil emerging as a key player. One of their flagship products, Cresemba (isavuconazole), has demonstrated strong sales performance, particularly in the Asia Pacific […]